Pado pcDNA3.1 Citations (7)

Originally described in: Pado, a fluorescent protein with proton channel activity can optically monitor membrane potential, intracellular pH, and map gap junctions.
Kang BE, Baker BJ Sci Rep. 2016 Apr 4;6:23865. doi: 10.1038/srep23865. PubMed Journal

---

Articles Citing Pado pcDNA3.1

Articles
CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance. Nilsson MB, Yang Y, Heeke S, Patel SA, Poteete A, Udagawa H, Elamin YY, Moran CA, Kashima Y, Arumugam T, Yu X, Ren X, Diao L, Shen L, Wang Q, Zhang M, Robichaux JP, Shi C, Pfeil AN, Tran H, Gibbons DL, Bock J, Wang J, Minna JD, Kobayashi SS, Le X, Heymach JV. Cancer Cell. 2023 Feb 13;41(2):340-355.e6. doi: 10.1016/j.ccell.2023.01.007. PubMed
Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson's disease. Stahn L, Rasinska J, Dehne T, Schreyer S, Hakus A, Gossen M, Steiner B, Hemmati-Sadeghi S. Drug Deliv Transl Res. 2023 Jun;13(6):1745-1765. doi: 10.1007/s13346-023-01289-9. Epub 2023 Feb 28. PubMed
Breast metastatic tumors in lung can be substituted by lung-derived malignant cells transformed by alternative splicing H19 lncRNA. Xu JB, Cao J, Xia J, Zhu Y, He Y, Cao MG, Fang BM, Thiery JP, Zhou W. Breast Cancer Res. 2023 May 30;25(1):59. doi: 10.1186/s13058-023-01662-z. PubMed
Sulfatase 2 Inhibition Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy Through Augmentation of Extracellular ATP. Manouchehri JM, Marcho L, Cherian MA. bioRxiv [Preprint]. 2023 Sep 17:2023.09.15.557965. doi: 10.1101/2023.09.15.557965. PubMed
Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis. Wang QM, Lian GY, Sheng SM, Xu J, Ye LL, Min C, Guo SF. Mol Cancer Res. 2024 Feb 1;22(2):125-136. doi: 10.1158/1541-7786.MCR-23-0282. PubMed
TNFRSF19 within the 13q12.12 Risk Locus Functions as a Lung Cancer Suppressor by Binding Wnt3a to Inhibit Wnt/beta-Catenin Signaling. Zuo X, Wang X, Ma T, Chen S, Cao P, Cheng H, Yang N, Han X, Gao W, Liu X, Sun Y. Mol Cancer Res. 2024 Mar 1;22(3):227-239. doi: 10.1158/1541-7786.MCR-23-0109. PubMed
Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer. Tam KJ, Liu L, Hsing M, Dalal K, Thaper D, McConeghy B, Yenki P, Bhasin S, Peacock JW, Wang Y, Cherkasov A, Rennie PS, Gleave ME, Ong CJ. Sci Rep. 2024 Mar 25;14(1):7082. doi: 10.1038/s41598-024-57854-w. PubMed

If you have published an article using this material, please email us at to have your article added to this page.